Mayne Pharma sells Adelaide plant to focus on US

Shareholders are betting on the sale of Mayne’s US operations once it no longer owns an Australian manufacturing site.

Reported by The Australian Financial Review. We will add other newspapers as they cover it. November 6, 2026, 02:27 UTC

How the newspaper covers this story

1. The Australian Financial ReviewAustraliaNovember 6, 2026, 02:27 UTC

   Mayne Pharma sells Adelaide plant to focus on US

   Shareholders are betting on the sale of Mayne’s US operations once it no longer owns an Australian manufacturing site.

   Read at The Australian Financial ReviewRead translated